China And Japan Oncology Markets Will Broaden Opportunity Amidst Headwinds
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 7 Analysts
Published
21 Jul 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
UK£3.67
35.5% undervalued intrinsic discount15 Aug
UK£2.37
1Y
-12.7%7D
1.3%